Ncs Multistage Holdings, Inc. · NASDAQ:NCSM

Ncs Multistage — Q4 2024 Earnings Presentation

24 slides from Ncs Multistage's earnings presentation, Mar 11, 2025

  1. Slide 1: Investor Update

    Investor Update March 2025

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements The information in this presentation includes “forward-looking statements” that are subject to risks and uncertainties. All statements, other than statements of historical fact included in this presentation, regarding NCS Multistage Holdings, Inc.’s (the “Compan

  3. Slide 3: The NCS Investment Proposition

    The NCS Investment Proposition 1. Leadership positions across a focused and Trading Statistics and differentiated portfolio of products and services Selected Financial Metrics* (In millions, except per share amounts) • We enable our customers to operate Share Price (3/7/2025) $25.49 more efficiently

  4. Slide 4: Our Technologies

    Our Technologies

  5. Slide 5: Fracturing Systems – Pinpoint Stimulation

    Fracturing Systems – Pinpoint Stimulation Pinpoint stimulation enables more predictable, repeatable and verifiable completions that maximize reservoir connectivity, as compared to other completion methods Other Completion Methods Pinpoint Stimulation Well 1 Well 2 Well 3 Well 4 Unpredictable frac si

  6. Slide 6: Fracturing Systems

    Fracturing Systems InnovusTM Casing-Installed MultiCycle® Frac Sleeve Applications Frac ports Outer barrel Sliding inner barrel Locator profile • Fracturing control • Selective production / injection • Solids control • Water, gas and CO2 injection • Tracer integration InnovusTM Downhole Frac-Isolati

  7. Slide 7: Repeat Precision Joint Venture

    Repeat Precision Joint Venture • PurpleSeal & PurpleReign frac plug family of products • 4.5”, 5.5” and 6.0” specifications • All-composite designs and hybrid bridge plug • Dissolvable plug configurable for high & low salinity as well as hot & cool wellbore environments • FracSure Express disposable

  8. Slide 8: Tracer Diagnostics

    Tracer Diagnostics Leading provider of chemical and radioactive tracers for well diagnostics and reservoir characterization • Cost-effective and reliable service utilized by E&P companies to optimize completion designs and field development • Growing portfolio of chemical tracers, including: − FFI®

  9. Slide 9: How Customers Utilize Tracers

    How Customers Utilize Tracers Common Tracer Uses FirstView 3D interactive animation • Evaluate well spacing and diagnose frac hits • Fast, economical completion design optimization • Verify stage contributions • Evaluate cluster efficiency • Locate wellbore obstructions • Monitor waterflood and gas

  10. Slide 10: Well Construction

    Well Construction • Single-source provider of well construction solutions • Proprietary technologies to support casing and liner installation and for initial formation access ⁻ AirLock® casing buoyancy system ⁻ VectrasetTM, VecturonTM and SlimStimTM liner hanger assemblies ⁻ GoPortTM and InnovusTM t

  11. Slide 11: Expanded Addressable Market

    Expanded Addressable Market NCS has expanded its addressable market and diversified its business through organic sales and new product development, the Repeat Precision joint venture and the Tracer Diagnostics acquisition 2016 - $98 mm Revenue 2024 - $163 mm Revenue <10% ~20% 140+ 200+ ~10% Customer

  12. Slide 12: Growth and Financial Execution

    Growth and Financial Execution

  13. Slide 13: Executing on Our Long-Term Strategy

    Executing on Our Long-Term Strategy upon our leading market on international and innovative solutions to positions offshore opportunities complex customer challenges NCS Canada Revenue (CAD MM) NCS International Revenue (USD MM) • Higher temperature solutions • Expanded range of available sizes • So

  14. Slide 14: Q4 and Full Year December 2024 Financial Results

    Q4 and Full Year December 2024 Financial Results Q4 2024 Performance: • Total revenue of $45.0 million, a 28% increase compared to Q4 2023 FY ‘23 vs. ‘24 Results • U.S. revenue of $10.7 million; Canadian revenue of $29.8 million; International revenue of $4.4 million • Adjusted gross margin* of 43%,

  15. Slide 15: Q1 2025 and 2025 Full Year Financial Guidance

    Q1 2025 and 2025 Full Year Financial Guidance Q1 2025 Financial Guidance*: • Total revenue of $42 - $46 million • Adjusted gross margin of 39% - 42% • Adjusted EBITDA of $4.5 - $6.5 million • Depreciation and amortization expense of $1.3 - $1.4 million Full Year 2025 Financial Guidance*: • Total rev

  16. Slide 16: Revenue Profile

    Revenue Profile Revenue Contribution – Twelve Months Ended December 31, 2024 By Geography Product and Service Mix 16

  17. Slide 17: Key Market Drivers

    Key Market Drivers NCS’s business is most closely levered to drilling and completion activity U.S. Average Horizontal Land Rig Count Canada Average Land Rig Count International Average Land Rig Count Source: Baker Hughes 17

  18. Slide 18: Attractive Financial Profile

    Attractive Financial Profile Financial and operating model minimizes capital investment and maximizes free cash flow Revenue (millions) Adjusted Gross Profit* (millions) and Margin% +13% Adjusted EBITDA* (millions) and Margin% Free Cash Flow* (millions) +49% * See Appendix for Adjusted Gross Profit,

  19. Slide 19: The NCS Investment Proposition

    The NCS Investment Proposition 1. Leadership positions across a focused and Trading Statistics and differentiated portfolio of products and services Selected Financial Metrics* (In millions, except per share amounts) • We enable our customers to operate Share Price (3/7/2025) $25.49 more efficiently

  20. Slide 20: Appendix

    Appendix

  21. Slide 21: Guided by The Promise

    Guided by The Promise We will invest in our employees, our most important resource, by providing coaching and training that enables them to learn and grow to their full potential. Together, we will maintain a culture that promotes teamwork and Employees an environment that is challenging, rewarding

  22. Slide 22: Adjusted EBITDA Reconciliation

    Adjusted EBITDA Reconciliation Year Ended Three Months December 31, Ended December 31, ($ in millions) 2020 2021 2022 2023 2024 2023 2024 Net income (loss) $ (39.1) $ (3.8) $ (1.0) $ (3.1) $ 8.1 $ 39.8 $ 3.7 Income tax expense (benefit) (7.8) 0.3 0.4 (0.2) 0.1 0.1 (0.6) Interest expense 1.8 0.7 1.0

  23. Slide 23: Adjusted Gross Profit and Adjusted Gross Margin Reconciliation

    Adjusted Gross Profit and Adjusted Gross Margin Reconciliation Year Ended Three Months December 31, Ended December 31, ($ in millions) 2023 2024 2023 2024 Total revenues $ 142.5 $ 162.6 $ 35.2 $ 45.0 Total cost of sales, exclusive of DD&A 86.9 95.1 22.4 25.6 Total DD&A associated with cost of sales

  24. Slide 24: Free Cash Flow and Net Working Capital Reconciliations

    Free Cash Flow and Net Working Capital Reconciliations Free Cash Flow Net Working Capital * Includes purchase and development of software and technology 24

NCS Multistage Holdings — Q4 2024 Earnings Presentation on 6ix